JP2012502678A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502678A5 JP2012502678A5 JP2011526514A JP2011526514A JP2012502678A5 JP 2012502678 A5 JP2012502678 A5 JP 2012502678A5 JP 2011526514 A JP2011526514 A JP 2011526514A JP 2011526514 A JP2011526514 A JP 2011526514A JP 2012502678 A5 JP2012502678 A5 JP 2012502678A5
- Authority
- JP
- Japan
- Prior art keywords
- heparin
- layer
- polyamine
- cationic polymer
- heparin moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical group OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 27
- 229960002897 heparin Drugs 0.000 claims 27
- 229920000669 heparin Polymers 0.000 claims 27
- 229920006317 cationic polymer Polymers 0.000 claims 14
- 229920000768 polyamine Polymers 0.000 claims 13
- 125000002355 alkine group Chemical group 0.000 claims 12
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims 12
- 239000010410 layer Substances 0.000 claims 11
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims 8
- 239000002344 surface layer Substances 0.000 claims 8
- 238000000034 method Methods 0.000 claims 6
- 229920006318 anionic polymer Polymers 0.000 claims 5
- 230000001453 nonthrombogenic effect Effects 0.000 claims 5
- 239000011247 coating layer Substances 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- 150000004804 polysaccharides Chemical class 0.000 claims 3
- 102000004411 Antithrombin III Human genes 0.000 claims 2
- 108090000935 Antithrombin III Proteins 0.000 claims 2
- 229960005348 antithrombin iii Drugs 0.000 claims 2
- 230000027455 binding Effects 0.000 claims 2
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 229920001586 anionic polysaccharide Polymers 0.000 claims 1
- 150000004836 anionic polysaccharides Chemical class 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 229960000633 dextran sulfate Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0816783.5A GB0816783D0 (en) | 2008-09-15 | 2008-09-15 | Immobilised biological entities |
| GB0816783.5 | 2008-09-15 | ||
| PCT/EP2009/061981 WO2010029189A2 (en) | 2008-09-15 | 2009-09-15 | Immobilised biological entities |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015047952A Division JP6122052B2 (ja) | 2008-09-15 | 2015-03-11 | 固定化生物学的実体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502678A JP2012502678A (ja) | 2012-02-02 |
| JP2012502678A5 true JP2012502678A5 (enExample) | 2012-12-27 |
| JP5775454B2 JP5775454B2 (ja) | 2015-09-09 |
Family
ID=39930120
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526514A Active JP5775454B2 (ja) | 2008-09-15 | 2009-09-15 | 固定化生物学的実体 |
| JP2015047952A Active JP6122052B2 (ja) | 2008-09-15 | 2015-03-11 | 固定化生物学的実体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015047952A Active JP6122052B2 (ja) | 2008-09-15 | 2015-03-11 | 固定化生物学的実体 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8992963B2 (enExample) |
| EP (1) | EP2340057B1 (enExample) |
| JP (2) | JP5775454B2 (enExample) |
| AU (1) | AU2009290833B2 (enExample) |
| CA (1) | CA2732939C (enExample) |
| ES (1) | ES2550147T3 (enExample) |
| GB (1) | GB0816783D0 (enExample) |
| WO (1) | WO2010029189A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8021677B2 (en) | 2006-05-12 | 2011-09-20 | Gore Enterprise Holdings, Inc. | Immobilized biologically active entities having a high degree of biological activity |
| US8496953B2 (en) | 2006-05-12 | 2013-07-30 | W. L. Gore & Associates, Inc. | Immobilized biologically active entities having a high degree of biological activity following sterilization |
| US9114194B2 (en) | 2006-05-12 | 2015-08-25 | W. L. Gore & Associates, Inc. | Immobilized biologically active entities having high biological activity following mechanical manipulation |
| US8986713B2 (en) | 2006-05-12 | 2015-03-24 | W. L. Gore & Associates, Inc. | Medical device capable of being compacted and expanded having anti-thrombin III binding activity |
| GB0816783D0 (en) * | 2008-09-15 | 2008-10-22 | Carmeda Ab | Immobilised biological entities |
| US8591932B2 (en) | 2009-09-17 | 2013-11-26 | W. L. Gore & Associates, Inc. | Heparin entities and methods of use |
| GB201004101D0 (en) * | 2010-03-12 | 2010-04-28 | Carmeda Ab | Immobilised biological entities |
| EP3375462B1 (en) | 2011-03-11 | 2023-06-07 | W. L. Gore & Associates, Inc. | Improvements to immobilised biological entities |
| WO2014152423A1 (en) * | 2013-03-15 | 2014-09-25 | Bard Access Systems, Inc. | Antithrombic coatings and uses thereof |
| JP6185662B2 (ja) * | 2013-09-30 | 2017-08-23 | テレフレックス メディカル インコーポレイテッド | 安定化酵素組成物 |
| US9795721B2 (en) * | 2013-11-28 | 2017-10-24 | Toray Industries, Inc. | Antithrombotic material |
| US11839698B2 (en) | 2014-03-13 | 2023-12-12 | W. L. Gore & Associates, Inc. | Drug composition and coating |
| WO2015188716A1 (zh) * | 2014-06-09 | 2015-12-17 | 上海微创医疗器械（集团）有限公司 | 一种抗凝血涂层及其涂覆方法 |
| RU2675107C1 (ru) * | 2015-05-27 | 2018-12-17 | Торэй Индастриз, Инк. | Антитромботический материал |
| US20190275213A1 (en) | 2018-03-09 | 2019-09-12 | Carmeda Ab | Immobilising biological entities |
| ES2953184T3 (es) * | 2018-03-09 | 2023-11-08 | Carmeda Ab | Mejoras en procesos de inmovilización de entidades biológicas |
| WO2020070258A1 (en) | 2018-10-03 | 2020-04-09 | Carmeda Ab | Immobilised biological entities |
| JP2023539452A (ja) * | 2020-08-14 | 2023-09-14 | イドリス・オンコロジー・ベーフェー | 生物分析物に対して結合親和性を有する１種又は複数の多糖を含むコーティングを医療用サンプリングデバイスの表面上に適用するための方法、及び生物分析物を捕捉するための該コーティングを備えた医療用サンプリングデバイス |
| EP4032560A1 (en) * | 2021-01-25 | 2022-07-27 | Centre National pour la Recherche Scientifique | Implantable material in contact with blood and uses thereof |
| US11685856B2 (en) * | 2021-05-21 | 2023-06-27 | Baker Hughes Oilfield Operations Llc | Branched polyethyleneimine (B-PE) as oilfield metal naphthenate inhibitors |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2818376A (en) * | 1956-12-28 | 1957-12-31 | Hanson Van Winkle Munning Co | Nickel plating |
| GB1508823A (en) | 1974-04-01 | 1978-04-26 | Oxy Metal Industries Corp | Electrodeposition of metal deposits |
| SE456347B (sv) | 1982-02-09 | 1988-09-26 | Ird Biomaterial Ab | Ytmodifierat fast substrat samt forfarande for framstellning derav |
| SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
| HU186656B (en) | 1982-12-28 | 1985-09-30 | Richter Gedeon Vegyeszet | Process for producing new benzhydryl-piperazine derivatives, acid additionak salts and pharmaceutical compositions containing them |
| JPH09103481A (ja) | 1989-05-11 | 1997-04-22 | Kanegafuchi Chem Ind Co Ltd | 生体適合性に優れた表面を有する医療用具およびその製造方法 |
| JPH0357896A (ja) * | 1989-07-26 | 1991-03-13 | Zexel Corp | 可変容量型ベーン型圧縮機 |
| JP2710444B2 (ja) | 1989-09-18 | 1998-02-10 | 旭化成工業株式会社 | 医療材料の製造法 |
| US5213898A (en) * | 1989-10-12 | 1993-05-25 | Norsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
| US5049403A (en) | 1989-10-12 | 1991-09-17 | Horsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
| JPH07122048B2 (ja) | 1989-11-30 | 1995-12-25 | テルモ株式会社 | 官能基導入基材およびその製造方法ならびにこれらを用いた医療用材料および医療用器具 |
| JP3093375B2 (ja) | 1991-11-01 | 2000-10-03 | 株式会社東海メディカルプロダクツ | 抗血栓性物質の固定化方法 |
| DE19604173C2 (de) | 1996-02-06 | 2000-07-06 | Hartwig Hoecker | Verfahren zur Erzeugung antithrombogener Oberflächen auf extrakorporal und/oder intrakorporal zu verwendenden medizinischen Gegenständen |
| US5855618A (en) * | 1996-09-13 | 1999-01-05 | Meadox Medicals, Inc. | Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
| NO984144L (no) * | 1998-09-09 | 2000-03-10 | Carmeda Ab | Sammensetning som omfatter heparin som et ikke-trombogent overflatebelegg |
| NO984143L (no) * | 1998-09-09 | 2000-03-10 | Norsk Hydro As | Ny prosess for å fremstille overflatemodifiserende stoffer |
| AU755683B2 (en) | 1998-11-10 | 2002-12-19 | Netech Inc. | Functional chitosan derivative |
| SE515295C2 (sv) * | 1999-11-23 | 2001-07-09 | Medicarb Ab | Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat |
| AU2001238485A1 (en) | 2000-02-18 | 2001-08-27 | The Immune Response Corporation | Methods and compositions for gene delivery |
| JP4071938B2 (ja) * | 2001-01-18 | 2008-04-02 | 富士フイルム株式会社 | インクジェット記録用シート |
| US20050059068A1 (en) * | 2001-05-23 | 2005-03-17 | Stratagene California | Compositions and methods using dendrimer-treated microassays |
| US6787179B2 (en) * | 2001-06-29 | 2004-09-07 | Ethicon, Inc. | Sterilization of bioactive coatings |
| MXPA04002554A (es) | 2001-09-18 | 2004-05-31 | Univ Zuerich | Metodos y aparatos para revestir superficies para reducir la adsorcion de proteinas y la adhesion celular y presentar ligandos. |
| IL164947A (en) * | 2002-05-09 | 2009-06-15 | Hemoteq Ag | Medical products comprising a haemocompatible coating and methods for their production |
| KR101138643B1 (ko) * | 2002-05-30 | 2012-04-26 | 더 스크립스 리서치 인스티튜트 | 구리 촉매 작용하에서의 아지드와 아세틸렌과의 리게이션 |
| US20050032081A1 (en) * | 2002-12-13 | 2005-02-10 | Jingyue Ju | Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry |
| DK1603603T3 (en) * | 2003-02-28 | 2015-02-23 | Biointeractions Ltd | Polymeric network systems for medical devices and methods of use |
| US9561309B2 (en) * | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
| AU2005266902A1 (en) * | 2004-07-22 | 2006-02-02 | The Scripps Research Institute | Polymeric materials via click chemistry |
| US9290617B2 (en) | 2005-07-06 | 2016-03-22 | Molly S. Shoichet | Method of biomolecule immobilization on polymers using click-type chemistry |
| US20070020620A1 (en) * | 2005-07-14 | 2007-01-25 | Finn M G | Compositions and methods for coupling a plurality of compounds to a scaffold |
| EP1934265A4 (en) | 2005-09-15 | 2009-06-24 | Univ Utah Res Found | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME |
| US7811555B2 (en) | 2005-12-30 | 2010-10-12 | Cordis Corporation | Tri-branched biologically active copolymer |
| US8114636B2 (en) | 2006-02-10 | 2012-02-14 | Life Technologies Corporation | Labeling and detection of nucleic acids |
| US8986713B2 (en) | 2006-05-12 | 2015-03-24 | W. L. Gore & Associates, Inc. | Medical device capable of being compacted and expanded having anti-thrombin III binding activity |
| US8021677B2 (en) * | 2006-05-12 | 2011-09-20 | Gore Enterprise Holdings, Inc. | Immobilized biologically active entities having a high degree of biological activity |
| EP2052045A4 (en) * | 2006-08-18 | 2012-09-12 | Commw Scient Ind Res Org | POLYMERIC COATINGS AND METHODS FOR FORMING SAME |
| ITMI20061726A1 (it) | 2006-09-11 | 2008-03-12 | Fidia Farmaceutici | Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry |
| WO2008090555A2 (en) | 2007-01-22 | 2008-07-31 | Elutex Ltd. | Medical devices having a matrix adhered thereof |
| US20090018646A1 (en) * | 2007-07-10 | 2009-01-15 | Zhao Jonathon Z | Coating Employing an Anti-Thrombotic Conjugate |
| FR2920435A1 (fr) | 2007-08-29 | 2009-03-06 | Arkema France | Compositions aqueuses acides de nettoyage, leur procede de preparation et leur utilisation |
| FR2920436A1 (fr) | 2007-08-30 | 2009-03-06 | Rhodia Operations Sas | Composition de traitement de fils ou fibres d'articles textiles |
| GB0816783D0 (en) * | 2008-09-15 | 2008-10-22 | Carmeda Ab | Immobilised biological entities |
| GB201004101D0 (en) | 2010-03-12 | 2010-04-28 | Carmeda Ab | Immobilised biological entities |
-
2008
- 2008-09-15 GB GBGB0816783.5A patent/GB0816783D0/en not_active Ceased
-
2009
- 2009-09-15 ES ES09783061.6T patent/ES2550147T3/es active Active
- 2009-09-15 CA CA2732939A patent/CA2732939C/en active Active
- 2009-09-15 JP JP2011526514A patent/JP5775454B2/ja active Active
- 2009-09-15 AU AU2009290833A patent/AU2009290833B2/en active Active
- 2009-09-15 EP EP09783061.6A patent/EP2340057B1/en active Active
- 2009-09-15 US US12/559,660 patent/US8992963B2/en active Active
- 2009-09-15 WO PCT/EP2009/061981 patent/WO2010029189A2/en not_active Ceased
-
2014
- 2014-09-19 US US14/490,891 patent/US10064978B2/en active Active
-
2015
- 2015-03-11 JP JP2015047952A patent/JP6122052B2/ja active Active
-
2018
- 2018-07-23 US US16/042,945 patent/US20180326118A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502678A5 (enExample) | ||
| Feng et al. | Tailoring the swelling‐shrinkable behavior of hydrogels for biomedical applications | |
| Yang et al. | Ultrafast and programmable shape memory hydrogel of gelatin soaked in tannic acid solution | |
| El Sayed | Production of polymer hydrogel composites and their applications | |
| Zheng et al. | Polysaccharide-based nanocomposites and their applications | |
| Moulay | Poly (vinyl alcohol) functionalizations and applications | |
| Ong et al. | Nanocellulose: Recent advances toward biomedical applications | |
| Qi et al. | Salecan-based pH-sensitive hydrogels for insulin delivery | |
| Wang et al. | Polyelectrolyte hydrogels for tissue engineering and regenerative medicine | |
| Wang et al. | Structuring and shaping of mechanically robust and functional hydrogels toward wearable and implantable applications | |
| He et al. | Intelligent cellulose nanofibers with excellent biocompatibility enable sustained antibacterial and drug release via a pH-responsive mechanism | |
| Wu et al. | Layer-by-layer (LBL) self-assembled biohybrid nanomaterials for efficient antibacterial applications | |
| Deng et al. | Heparin-mimicking multilayer coating on polymeric membrane via LbL assembly of cyclodextrin-based supramolecules | |
| Silva et al. | pH responsiveness of multilayered films and membranes made of polysaccharides | |
| JP2014508610A5 (enExample) | ||
| JP2013521838A5 (enExample) | ||
| JP2007532572A5 (enExample) | ||
| Vilela et al. | Polysaccharide based hybrid materials: metals and metal oxides, graphene and carbon nanotubes | |
| JP2013538864A5 (enExample) | ||
| JP2005538418A5 (enExample) | ||
| Chen et al. | Effective drug carrier based on polyethylenimine-functionalized bacterial cellulose with controllable release properties | |
| JP2012506904A5 (enExample) | ||
| Alam et al. | Nanofiber-based systems for stimuli-responsive and dual drug delivery: present scenario and the way forward | |
| JP2012505917A5 (enExample) | ||
| JP2011502631A5 (enExample) |